Key facts
- This page summarizes Lori Goltermann's Form 4 filing for LifeStance Health Group, Inc. (LFST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2026, 19:34.
Lori Goltermann - 02 Jul 2026 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)
- Reporting relationship
- Director
- Issuer ticker
- LFST
- Reported as of
- 02 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2026, 19:34:53 UTC
- Prior SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Ryan Pardo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lori Goltermann filed Form 4 for LifeStance Health Group, Inc. (LFST) on 07 Jul 2026.
Change
- Previous filing in this sequence was filed on 17 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002062798
Primary reporting owner
Goltermann Lori
- Relationship
- Director
- Address
- C/O LIFESTANCE HEALTH GROUP, INC., 4800 N. SCOTTSDALE ROAD, SUITE 2500, SCOTTSDALE
- Signature
- By: /s/ Ryan Pardo, Attorney-in-Fact
- Signature date
- 07 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LFST
transaction
Common Stock
Award
- Transaction value
- Shares
- +35,492
- Change %
- Price
- $0.000000*
- Shares after
- 35,492
- Date
- 02 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes 35,492 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.